Silymarin induces insulin resistance through an increase of phosphatase and tensin homolog in Wistar rats.

PubWeight™: 0.77‹?›

🔗 View Article (PMC 3880317)

Published in PLoS One on January 03, 2014

Authors

Kai-Chun Cheng1, Akihiro Asakawa1, Ying-Xiao Li1, Hsien-Hui Chung2, Haruka Amitani1, Takatoshi Ueki3, Juei-Tang Cheng4, Akio Inui1

Author Affiliations

1: Department of Psychosomatic Internal Medicine, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
2: Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan City, Taiwan.
3: Department of Neuroanatomy, Hamamatsu University School of Medicine. Hamamatsu, Japan.
4: Department of Medical Research, Chi-Mei Medical Center, Yong Kang, Tainan City, Taiwan.

Articles cited by this

Influences of glucose loading and of injected insulin on hepatic glucose output. Ann N Y Acad Sci (1959) 8.62

Global challenges in liver disease. Hepatology (2006) 4.55

Milk thistle (Silybum marianum) for the therapy of liver disease. Am J Gastroenterol (1998) 2.74

Regulation of splanchnic and peripheral glucose uptake by insulin and hyperglycemia in man. Diabetes (1983) 2.45

Muscle-specific Pten deletion protects against insulin resistance and diabetes. Mol Cell Biol (2005) 1.93

Specific inhibition of PTEN expression reverses hyperglycemia in diabetic mice. Diabetes (2002) 1.91

2-NBDG as a fluorescent indicator for direct glucose uptake measurement. J Biochem Biophys Methods (2005) 1.55

Silymarin ascending multiple oral dosing phase I study in noncirrhotic patients with chronic hepatitis C. J Clin Pharmacol (2009) 1.37

Dietary feeding of silibinin inhibits advance human prostate carcinoma growth in athymic nude mice and increases plasma insulin-like growth factor-binding protein-3 levels. Cancer Res (2002) 1.36

Glucose transport in human skeletal muscle cells in culture. Stimulation by insulin and metformin. J Clin Invest (1992) 1.33

Milk thistle for the treatment of liver disease: a systematic review and meta-analysis. Am J Med (2002) 1.28

Silibinin inhibits colorectal cancer growth by inhibiting tumor cell proliferation and angiogenesis. Cancer Res (2008) 1.24

Nonalcoholic fatty liver disease and the metabolic syndrome. Minerva Cardioangiol (2006) 1.21

Suppression of advanced human prostate tumor growth in athymic mice by silibinin feeding is associated with reduced cell proliferation, increased apoptosis, and inhibition of angiogenesis. Cancer Epidemiol Biomarkers Prev (2003) 1.18

"Fluorescent glycogen" formation with sensibility for in vivo and in vitro detection. Glycoconj J (2007) 1.10

Antiproliferative and apoptotic effects of silibinin in rat prostate cancer cells. Prostate (2002) 1.10

Silymarin retards the progression of alcohol-induced hepatic fibrosis in baboons. J Clin Gastroenterol (2003) 1.09

Oral silibinin inhibits in vivo human bladder tumor xenograft growth involving down-regulation of survivin. Clin Cancer Res (2008) 1.08

Epigenetic and genetic alterations of PTEN in hepatocellular carcinoma. Hepatol Res (2007) 1.07

6-Fluoro-6-deoxy-D-glucose as a tracer of glucose transport. Am J Physiol Endocrinol Metab (2007) 1.06

PTEN and SHIP2 phosphoinositide phosphatases as negative regulators of insulin signalling. Arch Physiol Biochem (2006) 1.05

Cytoplasmic polyadenylation element binding protein deficiency stimulates PTEN and Stat3 mRNA translation and induces hepatic insulin resistance. PLoS Genet (2012) 1.03

Effects and mechanisms of silibinin on human hepatoma cell lines. World J Gastroenterol (2007) 1.02

Characterisation of the PTEN inhibitor VO-OHpic. J Chem Biol (2010) 1.01

Increased hypothalamic inflammation associated with the susceptibility to obesity in rats exposed to high-fat diet. Exp Diabetes Res (2012) 1.01

Silibinin efficacy against human hepatocellular carcinoma. Clin Cancer Res (2005) 1.00

Effect of taurine on biomarkers of oxidative stress in tissues of fructose-fed insulin-resistant rats. Singapore Med J (2005) 0.99

PTEN in liver diseases and cancer. World J Gastroenterol (2010) 0.97

Inhibition of retinoblastoma protein (Rb) phosphorylation at serine sites and an increase in Rb-E2F complex formation by silibinin in androgen-dependent human prostate carcinoma LNCaP cells: role in prostate cancer prevention. Mol Cancer Ther (2002) 0.97

The histologic spectrum of nonalcoholic fatty liver disease. Clin Liver Dis (2004) 0.94

A fluorescence method for measurement of glucose transport in kidney cells. Diabetes Technol Ther (2011) 0.93

Differences in the disposition of silymarin between patients with nonalcoholic fatty liver disease and chronic hepatitis C. Drug Metab Dispos (2011) 0.92

Hepatoprotection with a chloroform extract of Launaea procumbens against CCl4-induced injuries in rats. BMC Complement Altern Med (2012) 0.90

Silymarin and milk thistle extract may prevent the progression of diabetic nephropathy in streptozotocin-induced diabetic rats. Ren Fail (2010) 0.90

Prediction of insulin resistance with anthropometric measures: lessons from a large adolescent population. Diabetes Metab Syndr Obes (2012) 0.89

Magnolia dealbata Zucc and its active principles honokiol and magnolol stimulate glucose uptake in murine and human adipocytes using the insulin-signaling pathway. Phytomedicine (2011) 0.89

Rosiglitazone improves insulin sensitivity and baroreflex gain in rats with diet-induced obesity. J Pharmacol Exp Ther (2012) 0.88

PTEN inhibitors cause a negative inotropic and chronotropic effect in mice. Eur J Pharmacol (2010) 0.87

The relationship between polycystic ovary syndrome, glucose tolerance status and serum preptin level. Reprod Biol Endocrinol (2012) 0.87

The anti-diabetic properties of Guazuma ulmifolia Lam are mediated by the stimulation of glucose uptake in normal and diabetic adipocytes without inducing adipogenesis. J Ethnopharmacol (2008) 0.86

Metformin sensitizes insulin signaling through AMPK-mediated PTEN down-regulation in preadipocyte 3T3-L1 cells. J Cell Biochem (2011) 0.86

Silymarin inhibits cervical cancer cell through an increase of phosphatase and tensin homolog. Phytother Res (2011) 0.85

Activation of I2-imidazoline receptors by agmatine improved insulin sensitivity through two mechanisms in type-2 diabetic rats. Neurosci Lett (2009) 0.83

Silymarin potentiates the anti-inflammatory effects of Celecoxib on chemically induced osteoarthritis in rats. Phytomedicine (2012) 0.83

Intracerebroventricular administration of galanin antagonist sustains insulin resistance in adipocytes of type 2 diabetic trained rats. Mol Cell Endocrinol (2012) 0.83

Protective effects of silymarin against doxorubicin-induced toxicity. Asian Pac J Cancer Prev (2011) 0.82

Improvement of insulin resistance by Chlorella in fructose-rich chow-fed rats. Phytother Res (2011) 0.81

Silymarin decreases connective tissue growth factor to improve liver fibrosis in rats treated with carbon tetrachloride. Phytother Res (2012) 0.81

Silymarin regulates the cytochrome P450 3A2 and glutathione peroxides in the liver of streptozotocin-induced diabetic rats. Phytomedicine (2012) 0.81

Chronic treatment of silymarin improves hyperalgesia and motor nerve conduction velocity in diabetic neuropathic rat. Phytother Res (2010) 0.80

Proposed cutoff level of waist circumference in Japanese men: evaluation by homeostasis model assessment of insulin resistance levels. Intern Med (2012) 0.78

Effects of silymarin (hepatoprotector) and succinic acid (bioenergy regulator) on metabolic disorders in experimental diabetes mellitus. Bull Exp Biol Med (2007) 0.77

Oral administration of Trapa taiwanensis Nakai fruit skin extracts conferring hepatoprotection from CCl4-caused injury. J Agric Food Chem (2011) 0.77

Influence of silymarin on drug metabolizing enzymes in rat and man. Arzneimittelforschung (1976) 0.77

Articles by these authors

Hydrogen improves glycemic control in type1 diabetic animal model by promoting glucose uptake into skeletal muscle. PLoS One (2013) 0.89

The role of adiponectin multimers in anorexia nervosa. Nutrition (2013) 0.82

Mechanism for increased hepatic glycerol synthesis in the citrin/mitochondrial glycerol-3-phosphate dehydrogenase double-knockout mouse: Urine glycerol and glycerol 3-phosphate as potential diagnostic markers of human citrin deficiency. Biochim Biophys Acta (2015) 0.81

Pharmacokinetic Profiles of Active Ingredients and Its Metabolites Derived from Rikkunshito, a Ghrelin Enhancer, in Healthy Japanese Volunteers: A Cross-Over, Randomized Study. PLoS One (2015) 0.79

Role of musclin in the pathogenesis of hypertension in rat. PLoS One (2013) 0.78

Comparison of gut hormones and adipokines stimulated by glucagon test among patients with type II diabetes mellitus after metabolic surgery. Neuropeptides (2015) 0.77

Activation of imidazoline-I3 receptors ameliorates pancreatic damage. Clin Exp Pharmacol Physiol (2015) 0.77

An Adolescent Case of Citrin Deficiency With Severe Anorexia Mimicking Anorexia Nervosa. Pediatrics (2015) 0.77

Case Report: A Non-small Cell Lung Cancer Patient Treated with GcMAF, Sonodynamic Therapy and Tumor Treating Fields. Anticancer Res (2016) 0.76

Alteration of loperamide-induced prostate relaxation in high-fat diet-fed rats. ScientificWorldJournal (2014) 0.75

Rosmarinic acid ameliorates hyperglycemia and insulin sensitivity in diabetic rats, potentially by modulating the expression of PEPCK and GLUT4. Drug Des Devel Ther (2016) 0.75

Activation of α7 nicotinic receptors suppresses sucrose addiction in mice. Prog Neuropsychopharmacol Biol Psychiatry (2021) 0.75